You are here: Home » 2023 » June » Archives for 27th

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bancor v3 Liquidity Providers to Secure Counsel Before Important Deadline in Securities Class Action Against BProtocol Foundation, Bancor DAO, Galia Benartzi, Guy Benartzi, Eyal Hertzog, and Yehuda Levy

NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds U.S.–based investors, also called liquidity providers ("LPs"), in Bancor Version 3 ("Bancor v3") between May 11, 2022 and May 11, 2023, inclusive (the "Class Period"), of the important July 14, 2023 lead plaintiff deadline.

The lawsuit is against BProtocol Foundation, Bancor DAO, Galia Benartzi, Guy Benartzi, Eyal Hertzog, and Yehuda Levy (together, "Defendants").

SO WHAT: If you invested, or provided liquidity, in Bancor v3 during the Class Period and are a U.S. resident you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Bancor v3 class action, go to https://rosenlegal.com/submit–form/?case_id=16271 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Defendants violated the federal securities laws and various state laws by offering and selling investment contracts to Bancor v3 liquidity providers, without registering under applicable federal securities laws as an exchange or broker–dealer, and without a registration statement in effect for the securities offered and sold. The lawsuit also alleges that the Defendants concealed and misrepresented material information concerning the risks associated with providing liquidity to Bancor v3.

To join the Bancor v3 class action, go to https://rosenlegal.com/submit–form/?case_id=16271 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8865545)

ROSEN, SKILLED INVESTOR COUNSEL, Encourages DouYu International Holdings Limited Investors with Losses to Secure Counsel Before Important Deadline in the Securities Class Action First Filed by the Firm – DOYU

NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DouYu International Holdings Limited (NASDAQ: DOYU) between April 30, 2021 and May 9, 2023, both dates inclusive (the "Class Period") of the important August 8, 2023 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased DouYu securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the DouYu class action, go to https://rosenlegal.com/submit–form/?case_id=15999 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose, among other things, that: (1) The Chinese government, due to concerns about issues such as video game and computer addiction, as well as content challenging its authority, could become increasingly aggressive towards DouYu regardless of how effective or sincere its attempts to comply with Chinese law were; (2) this increasingly aggressive posture subjected DouYu to a heightened risk of an investigation and subsequent government enforcement action and ultimately resulted in enforcement action; and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the DouYu class action, go to https://rosenlegal.com/submit–form/?case_id=15999 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm's attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8865549)

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CGC

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ: CGC) between May 31, 2022 and May 10, 2023, both dates inclusive (the "Class Period"), of the important July 24, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Canopy Growth securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Canopy Growth class action, go to https://rosenlegal.com/submit–form/?case_id=16092 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 24, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) there were material weaknesses in Canopy Growth's internal controls over accounting and financial reporting; (2) as a result, Canopy Growth improperly booked sales of its BioSteel business unit; (3) as a result, Canopy Growth's revenue was overstated; and (4) as a result of the foregoing, defendants' positive statements about Canopy Growth's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Canopy Growth class action, go to https://rosenlegal.com/submit–form/?case_id=16092 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8865547)

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cutera, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CUTR

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cutera, Inc. (NASDAQ: CUTR) between February 17, 2021 and May 9, 2023, both dates inclusive (the "Class Period") of the important July 24, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Cutera securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Cutera class action, go to https://rosenlegal.com/submit–form/?case_id=16520 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 24, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) overstated the sustainability of Cutera's revenue growth; (2) failed to disclose significant conflicts among members of the Company's senior leadership and Board; (3) failed to disclose several material weaknesses in the Company's internal control over financial reporting; and (4) as a result of the foregoing, and the significant decline in the market value of the Company's common stock, Plaintiff and other members of the Class suffered significant damages. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Cutera class action, go to https://rosenlegal.com/submit–form/?case_id=16520 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8865518)

Sensegen launches bio-based Exotic Flavors collection

Rancho Santa Margarita, Calif., June 27, 2023 (GLOBE NEWSWIRE) — Sensegen, the pioneering biotechnology–based solution provider in taste, smell, and beauty, has launched its highly anticipated Exotic Flavors collection.

Sensegen has created a range of captivating flavors for food and beverages. The collection features six unique exotic true–to–fruit flavors: lychee, guava, papaya, yuzu, dragon fruit, and violet.

“We are thrilled to introduce the Exotic Flavors collection to the market, representing a significant milestone in our mission to redefine taste and consumer experiences," said Natasha D'Souza, VP of Flavors and Consumer Experience at Sensegen.

"Our research has revealed that exotic flavors transcend vacation settings and have become a top preference for various occasions and drink preferences. By leveraging our bio–based solutions, we invite food and beverage companies to explore the immense potential of these flavors across different categories and create truly personalized experiences for their consumers," said D'Souza.

According to Sensegen's Sensory and Consumer Insights Center, 48% of consumers identified exotics as a top flavor. Consumers are open to more adventurous flavors in social settings or when they feel exploratory. In alcoholic beverages, consumers consider unique, exotic, and natural flavors as the top three desired characteristics.

Sensegen will unveil the Exotic Flavors collection at IFT First in Chicago, July 17–19, 2023, at its creative partner Blue California's booth S1670. In anticipation of the collection, IFT attendees will be the first to taste food and beverage prototypes made with the flavors and complimentary ingredients from Sensegen's sugar reduction solutions partner Sweegen.

What to Experience at IFT First 2023
IFT Attendees can expect several exciting prototypes to inspire their products with the Exotic Flavors.
A sneak preview is below.

  • Yuzu–flavored iced tea featuring Sensegen's yuzu natural flavor with Blue California's longevity vitamin ergothioneine and Sweegen's Signature Stevia and taste modulation solutions.
  • Dark chocolate truffles flavored with Sensegen lychee and natural violet flavor.
  • A better–for–you Guava energy drink made with Sensegen's guava natural flavor and 50% reduced sugar with Sweegen's Sweetensify Flavors for taste modulation. Guava has risen 22% YOY in beverages and 5% on restaurant menus.
  • Papaya–flavored refresher featuring Sensegen's papaya natural flavor. Papaya has increased by 19% on restaurant menus.
  • Dragon fruit–flavored sparkling water flavored with Sensegen's dragon fruit natural flavor.

This launch results from Sensegen's relentless pursuit of innovation and commitment to providing consumers with unique taste experiences. The Exotic Flavors collection is supported by the company's proprietary quantitative research conducted nationally with over 1,500 consumers. This comprehensive study explored the beverage and food choices people make in various situations, the influence of mood on those decisions, and the underlying reasons behind them.

Sensegen's insights from this research offer invaluable guidance to food and beverage companies seeking to inspire innovation with mood–centric flavors. By understanding that mood, food, and beverage choices can vary significantly among individuals, industry players can use this research to tap into the full potential of their offerings and deliver tailored experiences to their diverse consumer base.

In line with Sensegen's commitment to sustainability and biotechnology, the Exotic Flavors collection is produced by bioconversion. This approach ensures the highest quality and authenticity while minimizing the environmental impact of flavor production.

###

About Sensegen
Sensegen is the science of good sense. We've got nature down to a science.

As a division of Blue California Ingredients, our innovative taste, smell, and beauty creative center is dedicated solely to delivering plant–based, natural, and sustainable solutions. Our diverse team of experts collaborates with advanced bio–techniques and collaborates as a team to provide unique consumer–validated ingredients.

At Sensegen, we've pioneered a way of formulating nature without compromise or harm, providing one–of–a–kind solutions for Taste, Smell, and Beauty.

Attachments


GLOBENEWSWIRE (Distribution ID 8865558)

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Icahn Enterprises L.P. Investors to Secure Counsel Before Important July 10 Deadline in Securities Class Action – IEP

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Icahn Enterprises L.P. (NASDAQ: IEP) between August 2, 2018 and May 9, 2023, both dates inclusive (the "Class Period"), of the important July 10, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Icahn Enterprises securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Icahn Enterprises class action, go to https://rosenlegal.com/submit–form/?case_id=16028 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 10, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Icahn Enterprises was inflating its net asset value; (2) Icahn Enterprises was using money taken in from new investors to pay out dividends to old investors; (3) as a result, Icahn Enterprises would become the subject of criminal and/or regulatory scrutiny; and (4) as a result of the foregoing, defendant's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Icahn Enterprises class action, go to https://rosenlegal.com/submit–form/?case_id=16028 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8865487)

Zoom brings together in-office and remote employees with the launch of Intelligent Director for Zoom Rooms

SAN JOSE, Calif., June 27, 2023 (GLOBE NEWSWIRE) — Today Zoom Video Communications, Inc. (NASDAQ: ZM) announced the launch of the award–winning Intelligent Director for Zoom Rooms. For hybrid meetings with a Zoom Room, Intelligent Director uses AI and multiple cameras to provide the best image and angle of participants in the room so remote participants can see each person clearly, even in large conference rooms.

"As more people return to the office, it's no longer enough to deliver the best remote worker experience; every business needs a solution to deliver the best hybrid meeting experience," said Smita Hashim, chief product officer at Zoom. "Even with some employees in the office, oftentimes other team members are dispersed, so meeting equity and inclusion become more important than ever. Intelligent Director is the solution that can bring employees together, regardless of location, so they can truly connect face–to–face."

Intelligent Director is specifically designed for medium– to larger–sized rooms and helps avoid the "bowling alley effect." Intelligent Director can individually frame up to 16 participants in a Zoom Room using multiple cameras, choosing the best video stream via a Zoom–designed AI, and send that stream to the gallery view of the Zoom Meeting.

An evolution of Zoom's Smart Gallery feature, which uses a single camera and AI to give each person in a small to medium–sized room their own space in a Zoom Meeting, Intelligent Director takes this same technology to the next level for larger conference rooms.

For bigger meeting spaces, it is easier to be hidden by others when only using a single camera, so Intelligent Director's multi–camera configuration and use of video AI technology provide meeting equity to everyone in the room, selecting the best view of each individual, even if they move around or turn their heads. Remote participants can now have face–to–face conversations with each Zoom Rooms participant, allowing in–room participants to be seen and heard.

Intelligent Director is made possible through the support of Zoom's hardware partner ecosystem. Manufacturers, including Apple, AVer, Dell, HP | Poly, Intel, Logitech, and Yealink have supported Zoom with the computer, controller, and camera solutions necessary to produce this major advancement.

About Zoom
Zoom is an all–in–one intelligent collaboration platform that makes connecting easier, more immersive, and more dynamic for businesses and individuals. Zoom technology puts people at the center, enabling meaningful connections, facilitating modern collaboration, and driving human innovation through solutions like team chat, phone, meetings, omnichannel cloud contact center, smart recordings, whiteboard, and more, in one offering. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more info at zoom.com.

Zoom Public Relations
Lacretia Taylor
press@zoom.us


GLOBENEWSWIRE (Distribution ID 8865322)

Medela Concludes Global Breastfeeding Symposium with Key Takeaways in Lactation Science to Inform Clinical Practice

Switzerland, Baar, June 27, 2023 (GLOBE NEWSWIRE) — Medela, the brand trusted by millions of moms*, concluded its 16th Global Breastfeeding and Lactation Symposium, focused on advancing lactation science to improve care. This three–part world tour was held in three locations, kicking off in Chicago, Illinois in April, followed by Beijing, China in May, and concluding in Munich, Germany in June. All three events welcomed more than 2,600 healthcare professionals in maternal and infant care to learn about the latest research findings and key insights from globally and regionally renowned experts in human milk and lactation. Delivering on Medela's commitment of turning science into care, speaker presentations from the series will be available free of charge for virtual access through Medela University from next week.

"By bringing together top minds in lactation science from around the world, we are able to further our shared goal of improving maternal and infant health outcomes," said Annette Brls, CEO of Medela worldwide. "We know that conducting the research is only half of a much larger picture, which is why our Global Symposium is committed to creating a dynamic learning opportunity to transfer this knowledge from the experts in science and research to the leaders in healthcare settings around the world. We are bridging the gap between research and practice, making it accessible, free of charge, to the people who use and need it, with the sole intention of nurturing health for generations."

The global event featured presentations and discussions from experts, including:

PROF. LARS BODE (USA) | Lactation as a biological system: The dynamics of human milk composition

"Human milk and lactation do not stand in isolation; they are part of a dynamic biological system that is embedded in socioeconomic, cultural, behavioral, and environmental contexts," explains Professor Bode, Ph.D., at the University of California San Diego. "As a scientist, it was exciting to participate in Medela's Breastfeeding & Lactation Symposia because the events connect the science with the clinical application of human milk and lactation, which together is a major driver to advance the field with maximum impact on infant health and development."

PROF. DONNA GEDDES (AU) | Lactation as a biological system: The importance of dose

"As we seek to understand how human milk composition impacts the health of our next generation, we often default to analyzing concentrations of milk components. Yet when we measure the dose the baby receives, a new world opens up with the promise of innovative ways to improve the health of our children," says Professor Geddes from the University of Western Australia. "I appreciate the opportunity to share my scientific findings at this stellar conference, but I find the interaction with the participants invaluable, as they come from all disciplines essential to improving breastfeeding and breast milk delivery for all lactating women and their babies."

DR. REBECCA HOBAN (CA) | Initiation of lactation: Prophylactic lactation support as standard of care for mothers of NICU infants

"Although we know that mother's milk is literally lifesaving for preterm infants in the NICU, many mothers struggle to make enough milk for their babies, limiting their infant's lifelong milk dose and it is my passion to optimize lactation for these vulnerable families," shares Dr. Hoban, staff neonatologist and Director of Breastfeeding Medicine at The Hospital for Sick Children in Toronto. "Medela's Symposium brings new lactation evidence to clinician leaders who will translate the science to the bedside for families around the world. It's a great way to "spread the word' about the latest findings in breastfeeding research!”

PROF. DIANE SPATZ (USA) | A call to action: Improving human milk and breastfeeding outcomes by prioritizing effective initiation of lactation

"There is a critical window for the establishment of a milk supply and, we as advocates and clinicians have an obligation to families to teach them the science of human milk and the physiology of lactation," explains Professor Diane Spatz, who also serves as chairperson for Medela's Scientific and Clinical Advisory Board in the Americas. Prof. Spatz presented a call to action about the need for prioritizing effective initiation of lactation in order to improve exclusivity and duration of breastfeeding. Prof. Spatz is a Professor of Perinatal Nursing at the University of Pennsylvania School of Nursing sharing a joint appointment at Children's Hospital of Philadelphia.

Held as a hybrid event in Beijing on May 13–14, the China Symposium focused on providing a platform for like–minded breastfeeding professionals to share ideas, experiences and best practices. In partnership with the China Maternity and Child Health Association, the event marked a shared commitment to educating individuals on the benefits of human milk, while strengthening the collective efforts to foster a supportive environment for breastfeeding in China.

PROF. CAO YUN (CHINA) | The impact of human milk feeding on the outcomes of NICU premature infants based on clinical research in China

"As an experienced NICU physician, I have been promoting human milk feeding since I learned of its benefits for NICU infants. I am pleased to see so many obstetrics, pediatrics, and nursing experts gathered here. The promotion of breastfeeding cannot be achieved without the cooperation of various departments and multi–disciplinary teams." says Prof. Cao Yun from Fudan University Children Hospital. "It is great that Medela organizes such an informative symposium that allows us to unite to promote breastfeeding in China."

PROF. YU HONG (CHINA) | Quality improvement study on breastfeeding in mother–infant–separation dyads after standardized interventions

"I was very excited to participate in this grand event organized by Medela and learned about global cutting–edge research," says Prof. Yu Hong from Southeast University Zhongda Hospital. "I led a multiple–center quality improvement study in Jiangsu Province, and our objective is to support lactation and improve the dose of own mother's milk feeding through the evidence–based interventions."

PROF. FENG QI (CHINA) | Clinical study on promoting breastfeeding of premature infants in China

"Breastfeeding is not only a mother's business, but also depends on family and social support," says Prof. Feng Qi from Peking University First Hospital. "At present, the government has issued documents to support breastfeeding, and we also have the consensus from professional groups. As more and more hospitals are paying increasing attention to breastfeeding, we need to proactively adopt best clinical practices to improve breastfeeding in the NICU."

DR. YUKI TAKAHASHI (JAPAN) | Effect of epidural analgesia on infant sucking and opportunities for improvement to achieve the standard of care for infants

"Intrapartum interventions such as epidural analgesia or induction of labor can influence skin–to–skin contact and rooting/suckling behavior, not only right after, but up to two days after birth," says Dr. Yuki Takahashi from Nagoya University Japan. "And the important thing is to prioritize breastfeeding support resources to provide behaviorally appropriate and individualized care during this critical period."

On June 23–24, Medela hosted the European Edition of their world tour in Munich, Germany, and welcomed two internationally renowned British speakers who shared their insights for improving lactation support in the neonatal intensive care unit. On day two of the symposium the healthcare experts on–site took these findings into curated workshops with the goal of translating them into clinical practice.

PROF. NEENA MODI (UK) | Perspectives: Prioritizing own mother s milk in the neonatal unit – need for standardized metrics that capture lactation and infant feeding

“Prioritizing the provision of own mother's milk (OMM) is a crucial step in neonatal care and thorough, high–quality data on lactation and infant feeding are fundamental in assessing the success of OMM provision and understanding the extent to which infants leave the neonatal unit breastfeeding," asserts Professor Neena Modi of the Imperial College London, who also serves as President–elect of the European Association of Perinatal Medicine. Prof. Modi underscored that by implementing standardized information recording in neonatal units, we can develop universally accepted quality indicators, improve care, and drive research for better breastfeeding outcomes.

DR. SARAH BATES (UK) | Spotlight: Improving survival & outcomes for preterm infants through optimizing early maternal breast milk – a national Quality Improvement toolkit from BAPM

"Optimizing own mother's milk (OMM) is crucial for the long–term health of preterm infants,” explained Dr. Sarah Bates, Consultant Pediatrician and Neonatologist at the Great Western Hospital in Swindon. In her talk Dr. Bates shed light on the innovative national toolkits created by the British Association of Perinatal Medicine, demonstrating its utility in optimizing OMM for preterm infants from initiation of lactation to post–discharge. Her session, infused with success stories and insightful parental views, showcased how this initiative can positively reshape the health trajectories of preterm infants nationwide.

Turning science into care

Presentations from speakers will be available free of charge for virtual access through Medela University, an online professional education platform for lactation science offering continuing education units (CEUs).

In addition, Medela will host a series of educational webinars in the US and Europe to translate existing research findings into clinical practice and share important conclusions and expert recommendations. While the US webinars will focus primarily on disparities in breastfeeding and resources for clinicians to assess their own implicit bias and alter clinical practice to better support Black women who breastfeed, the European webinars will focus on improving lactation science and improving care in neonatal units.

Learn more about the Global Breastfeeding and Lactation Symposium at medela.com/symposium.

Media resources, including language versions of the press releases and visual assets are available for download at medela.com/symposium–media.

About Medela

Through advancing research, observing natural behavior, and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients, and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides leading research–based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education. Medela is dedicated to building better health outcomes, simplifying and improving life, and developing breakthroughs that help moms, babies and patients live their life to the fullest. For more information, visit www.medela.com.

* Medela global sales, 2022

Attachments


GLOBENEWSWIRE (Distribution ID 8865260)

The USA’s Systemic Racism includes Its Wars

Anti-racism protesters in Brooklyn, New York, demonstrate demanding justice for the killing of African American, George Floyd. Credit: UN News/Shirin Yaseen

By Norman Solomon
SAN FRANCISCO, USA, Jun 27 2023 – A recent Justice Department report concluded that “systemic” racial bias in the Minneapolis Police Department “made what happened to George Floyd possible.”

During the three years since a white police officer brutally murdered Floyd, nationwide discussions of systemic racism have extended well beyond focusing on law enforcement to also assess a range of other government functions.

But such scrutiny comes to a halt at the water’s edge — stopping short of probing whether racism has been a factor in U.S. military interventions overseas.

Hidden in plain sight is the fact that virtually all the people killed by U.S. firepower in the “war on terror” for more than two decades have been people of color. This notable fact goes unnoted within a country where — in sharp contrast — racial aspects of domestic policies and outcomes are ongoing topics of public discourse.

Certainly, the U.S. does not attack a country because people of color live there. But when people of color live there, it is politically easier for U.S. leaders to subject them to warfare — because of institutional racism and often-unconscious prejudices that are common in the United States.

Racial inequities and injustice are painfully apparent in domestic contexts, from police and courts to legislative bodies, financial systems and economic structures. A nation so profoundly affected by individual and structural racism at home is apt to be affected by such racism in its approach to war.

Many Americans recognize that racism holds significant sway over their society and many of its institutions. Yet the extensive political debates and media coverage devoted to U.S. foreign policy and military affairs rarely even mention — let alone explore the implications of — the reality that the several hundred thousand civilians killed directly in America’s “war on terror” have been almost entirely people of color.

The flip side of biases that facilitate public acceptance of making war on non-white people came to the fore when Russia invaded Ukraine in early 2022. News coverage included reporting that the war’s victims “have blue eyes and blond hair” and “look like us,” Los Angeles Times television critic Lorraine Ali noted.

“Writers who’d previously addressed conflicts in the Gulf region, often with a focus on geopolitical strategy and employing moral abstractions, appeared to be empathizing for the first time with the plight of civilians.”

Such empathy, all too often, is skewed by the race and ethnicity of those being killed. The Arab and Middle Eastern Journalists Association has deplored “the pervasive mentality in Western journalism of normalizing tragedy in parts of the world such as the Middle East, Africa, South Asia and Latin America. It dehumanizes and renders their experience with war as somehow normal and expected.”

Persisting today is a modern version of what W.E.B. Du Bois called, 120 years ago, “the problem of the color line — the relation of the darker to the lighter races.” Twenty-first century lineups of global power and geopolitical agendas have propelled the United States into seemingly endless warfare in countries where few white people live.

Racial, cultural and religious differences have made it far too easy for most Americans to think of the victims of U.S. war efforts in Iraq, Afghanistan, Syria, Libya and elsewhere as “the other.”

Their suffering is much more likely to be viewed as merely regrettable or inconsequential rather than heart-rending or unacceptable. What Du Bois called “the problem of the color line” keeps empathy to a minimum.

“The history of U.S. wars in Asia, the Middle East, Africa and Latin America has exuded a stench of white supremacy, discounting the value of lives at the other end of U.S. bullets, bombs and missiles,” I concluded in my new book War Made Invisible. “Yet racial factors in war-making decisions get very little mention in U.S. media and virtually none in the political world of officials in Washington.”

At the same time, on the surface, Washington’s foreign policy can seem to be a model of interracial connection. Like presidents before him, Joe Biden has reached out to foreign leaders of different races, religions and cultures — as when he fist-bumped Saudi Arabia’s de facto ruler Crown Prince Mohammed bin Salman at their summit a year ago, while discarding professed human-rights concerns in the process.

Overall, in America’s political and media realms, the people of color who’ve suffered from U.S. warfare abroad have been relegated to a kind of psychological apartheid — separate, unequal, and implicitly not of much importance.

And so, when the Pentagon’s forces kill them, systemic racism makes it less likely that Americans will actually care.

Norman Solomon is the national director of RootsAction.org and executive director of the Institute for Public Accuracy. He is the author of a dozen books including War Made Easy. His latest book, War Made Invisible: How America Hides the Human Toll of Its Military Machine, was published in June 2023 by The New Press.

IPS UN Bureau

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Rohingya Camps Become Dengue Hotspots in Bangladesh

With the monsoon refugees in the cramped camps in Cox’s Bazar are expected to be impacted by an increase of dengue, which last year accounted for 1,283 cases in the Rohingya camps. Credit: Rafiqul Islam/IPS

With the monsoon refugees in the cramped camps in Cox’s Bazar are expected to be impacted by an increase of dengue, which last year accounted for 1,283 cases in the Rohingya camps. Credit: Rafiqul Islam/IPS

By Rafiqul Islam
DHAKA, Jun 27 2023 – With the monsoon in Bangladesh, Rohingya refugee camps in Cox’s Bazar have emerged as a dengue hotspot, with the mosquito-borne disease continuing to spread among the stateless refugees.

“A total of 1,066 dengue cases were reported in highly cramped refugee camps in Cox’s Bazar up to May 23 this year, while the case tally was only 426 among the local community there,” Dr Nazmul Islam, Director of Disease Control and Line of the Directorate General of Health Services (DGHS), said.

However, the latest data of the DGHS revealed that 1,283 people were infected with and 26 people died of dengue in the Rohingya camps and surrounding host community in Ukhiya and Teknaf upazilas of Cox’s Bazar from January 1 to June 6, 2023.

Nazmul said the dengue infection rate is highest in the Rohingya camps.

“Rohingya camps in Cox’s Bazar have the highest number of dengue patients. Last year, over 17,000 dengue patients were identified there. The number of dengue patients is so high this year, too,” he said.

Official data showed that dengue cases increased significantly in 2022 when the monsoon started. Experts fear the dengue situation will be more acute in the Rohingya camps during the monsoon this year.

Bangladesh witnessed its largest influx of Rohingya refugees in 2017 following a military crackdown in the Rakhine State of Myanmar. According to UNHCR, about 7,73,972 Rohingya people entered the country as refugees, totaling nearly 10 million with the previous influxes.

The forcibly displaced Rohingyas took shelter in overcrowded makeshift camps where they lacked access to civic amenities, including education, food, clean water, and proper sanitation, and also face natural disasters and infectious disease transmission.

“Most refugees have no adequate access to clean water, sanitary facilities, or healthcare. The monsoon season also poses a huge threat to thousands of Rohingya families living in makeshift shelters as dengue outbreak emerges in camps during the period,” said Ro Arfat, a Rohingya refugee.

Nazmul said Rohingya refugees live in a limited space in the camps where there is not enough scope to runoff rainwater, so stagnant water creates an enabling environment for the breeding Aedes mosquito, carrier of the dengue virus.

He said the risk of dengue infections climbs in densely populated areas. With the monsoon, the dengue situation could turn dangerous in the refugee camps.

Dr Iqbal Kabir, Professor and Director at the Climate Change and Health Promotion Unit, the Ministry of Health, Bangladesh, said in recent years, environmental changes have been markedly observed throughout the globe, and there is no exception in Bangladesh.

“The nature of the Aedes mosquito is that it must bite five humans to suck blood as per its demand, and an Aedes mosquito lays more than 200 eggs a time. Once they get suitable humidity and temperature, mosquito breeding occurs,” Kabir said.

He observed that dengue spreads very fast, but the authorities have not controlled dengue infections in the highly-crowded refugee camps in Cox’s Bazar.

During the monsoon, Bangladesh experiences spikes in dengue outbreaks. In 2022, 17 refugees died from dengue infections in Rohingya camps.

Despite having a high dengue infection rate in the camps, lack of awareness about the virus and the absence of prompt diagnosis of the disease make the Rohingya refugees more vulnerable.

“An Aedes mosquito can infect many within seconds, and keeping densely populated refugee camps safe from mosquitoes is really difficult. So there is a high possibility of a severe outbreak in the refugee camps,” said Mahbubur Rahman, Civil Surgeon, and Chief Health Officer for Cox’s Bazar.

Urgent Action Needed

The burden of dengue is related to the changes in rainfall patterns. The rainfall pattern has been changed. Pre-monsoon erratic rainfall is linked with the increase of vectors.

Unusual rainfall occurred in Cox’s Bazar area earlier this year, triggering dengue outbreaks in the camps.

Kabir said the dengue national guideline should be revisited to check dengue outbreaks across the country, including Rohingya camps.

He suggested launching a crash programme to prevent dengue infections in Rohingya camps; if clustering could be ensured, it would be easy to deal with the dengue situation there.

Golam Rabbani, head of BRAC’s Climate Bridge Fund, said the Bangladesh government should initiate research and increase the authorities’ capacity to tackle any future outbreak of dengue in the country.

He says the Department of Public Health and the DGHS should identify dengue as one of the most climate-sensitive diseases and improve their disease profile, suggesting the government initiate investment and policy interventions to address the dengue in Bangladesh.

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);